Selected research
Industry Growth & Trends
Global Bilastine Industry Growth and Trends Forecast to 2032
Market perspective
The global Bilastine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bilastine include Aralez Pharmaceuticals, Berlin Chemie, Faes Farma, Menarini, Pierre Fabre, Taiho Yakuhin, GlaxoSmithKline and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Bilastine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Bilastine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bilastine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bilastine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Bilastine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Bilastine Market by Company
Aralez Pharmaceuticals
Berlin Chemie
Faes Farma
Menarini
Pierre Fabre
Taiho Yakuhin
GlaxoSmithKline
Takeda
Bilastine Segment by Type
Hospital
Drug Store
Bilastine Segment by Application
Allergic Rhinoconjunctivitis
Allergic Rhinitis
Urticaria
Bilastine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bilastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bilastine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bilastine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bilastine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Bilastine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hospital
- Drug Store
Applications
- Allergic Rhinoconjunctivitis
- Allergic Rhinitis
- Urticaria
Companies covered
- Aralez Pharmaceuticals
- Berlin Chemie
- Faes Farma
- Menarini
- Pierre Fabre
- Taiho Yakuhin
- GlaxoSmithKline
- Takeda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bilastine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Bilastine Sales Estimates and Forecasts (2021-2032)
- 1.3 Bilastine Market by Type
- 1.3.1 Hospital
- 1.3.2 Drug Store
- 1.4 Global Bilastine Market Size by Type
- 1.4.1 Global Bilastine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Bilastine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Bilastine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Bilastine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Bilastine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Bilastine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Bilastine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Bilastine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Bilastine Industry Trends
- 2.2 Bilastine Industry Drivers
- 2.3 Bilastine Industry Opportunities and Challenges
- 2.4 Bilastine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Bilastine Revenue (2021-2026)
- 3.2 Global Top Players by Bilastine Sales (2021-2026)
- 3.3 Global Top Players by Bilastine Price (2021-2026)
- 3.4 Global Bilastine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bilastine Major Company Production Sites & Headquarters
- 3.6 Global Bilastine Company, Product Type & Application
- 3.7 Global Bilastine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Bilastine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Bilastine Players Market Share by Revenue in 2025
- 3.8.3 2025 Bilastine Tier 1, Tier 2, and Tier 3
4 Bilastine Regional Status and Outlook
- 4.1 Global Bilastine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Bilastine Historic Market Size by Region
- 4.2.1 Global Bilastine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Bilastine Sales in Value by Region (2021-2026)
- 4.2.3 Global Bilastine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Bilastine Forecasted Market Size by Region
- 4.3.1 Global Bilastine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Bilastine Sales in Value by Region (2027-2032)
- 4.3.3 Global Bilastine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bilastine by Application
- 5.1 Bilastine Market by Application
- 5.1.1 Allergic Rhinoconjunctivitis
- 5.1.2 Allergic Rhinitis
- 5.1.3 Urticaria
- 5.2 Global Bilastine Market Size by Application
- 5.2.1 Global Bilastine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Bilastine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Bilastine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Bilastine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Bilastine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Bilastine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Bilastine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Bilastine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Aralez Pharmaceuticals
- 6.1.1 Aralez Pharmaceuticals Company Information
- 6.1.2 Aralez Pharmaceuticals Business Overview
- 6.1.3 Aralez Pharmaceuticals Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Aralez Pharmaceuticals Bilastine Product Portfolio
- 6.1.5 Aralez Pharmaceuticals Recent Developments
- 6.2 Berlin Chemie
- 6.2.1 Berlin Chemie Company Information
- 6.2.2 Berlin Chemie Business Overview
- 6.2.3 Berlin Chemie Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Berlin Chemie Bilastine Product Portfolio
- 6.2.5 Berlin Chemie Recent Developments
- 6.3 Faes Farma
- 6.3.1 Faes Farma Company Information
- 6.3.2 Faes Farma Business Overview
- 6.3.3 Faes Farma Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Faes Farma Bilastine Product Portfolio
- 6.3.5 Faes Farma Recent Developments
- 6.4 Menarini
- 6.4.1 Menarini Company Information
- 6.4.2 Menarini Business Overview
- 6.4.3 Menarini Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Menarini Bilastine Product Portfolio
- 6.4.5 Menarini Recent Developments
- 6.5 Pierre Fabre
- 6.5.1 Pierre Fabre Company Information
- 6.5.2 Pierre Fabre Business Overview
- 6.5.3 Pierre Fabre Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Pierre Fabre Bilastine Product Portfolio
- 6.5.5 Pierre Fabre Recent Developments
- 6.6 Taiho Yakuhin
- 6.6.1 Taiho Yakuhin Company Information
- 6.6.2 Taiho Yakuhin Business Overview
- 6.6.3 Taiho Yakuhin Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Taiho Yakuhin Bilastine Product Portfolio
- 6.6.5 Taiho Yakuhin Recent Developments
- 6.7 GlaxoSmithKline
- 6.7.1 GlaxoSmithKline Company Information
- 6.7.2 GlaxoSmithKline Business Overview
- 6.7.3 GlaxoSmithKline Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GlaxoSmithKline Bilastine Product Portfolio
- 6.7.5 GlaxoSmithKline Recent Developments
- 6.8 Takeda
- 6.8.1 Takeda Company Information
- 6.8.2 Takeda Business Overview
- 6.8.3 Takeda Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Takeda Bilastine Product Portfolio
- 6.8.5 Takeda Recent Developments
7 North America by Country
- 7.1 North America Bilastine Sales by Country
- 7.1.1 North America Bilastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Bilastine Sales by Country (2021-2026)
- 7.1.3 North America Bilastine Sales Forecast by Country (2027-2032)
- 7.2 North America Bilastine Market Size by Country
- 7.2.1 North America Bilastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Bilastine Market Size by Country (2021-2026)
- 7.2.3 North America Bilastine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Bilastine Sales by Country
- 8.1.1 Europe Bilastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Bilastine Sales by Country (2021-2026)
- 8.1.3 Europe Bilastine Sales Forecast by Country (2027-2032)
- 8.2 Europe Bilastine Market Size by Country
- 8.2.1 Europe Bilastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Bilastine Market Size by Country (2021-2026)
- 8.2.3 Europe Bilastine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Bilastine Sales by Country
- 9.1.1 Asia-Pacific Bilastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Bilastine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Bilastine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Bilastine Market Size by Country
- 9.2.1 Asia-Pacific Bilastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Bilastine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Bilastine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Bilastine Sales by Country
- 10.1.1 South America Bilastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Bilastine Sales by Country (2021-2026)
- 10.1.3 South America Bilastine Sales Forecast by Country (2027-2032)
- 10.2 South America Bilastine Market Size by Country
- 10.2.1 South America Bilastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Bilastine Market Size by Country (2021-2026)
- 10.2.3 South America Bilastine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Bilastine Sales by Country
- 11.1.1 Middle East and Africa Bilastine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Bilastine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Bilastine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Bilastine Market Size by Country
- 11.2.1 Middle East and Africa Bilastine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Bilastine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Bilastine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Bilastine Value Chain Analysis
- 12.1.1 Bilastine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Bilastine Production Mode & Process
- 12.2 Bilastine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Bilastine Distributors
- 12.2.3 Bilastine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst